Clinical Trial Update: Exploratory Study on the Treatment of Relapsed and Refractory B-cell Malignant Tumors With WGb-0301 Injection [EARLY_Phase 1]

View source ↗

Summary

An early-phase exploratory study of WGb-0301 injection for relapsed and refractory B-cell malignancies, sponsored by Sichuan University, which is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Malignancies

Drugs mentioned

• WGb-0301 Injection

Snippet

Sponsor: Sichuan University | Conditions: B Cell Malignancies | EARLY_Phase 1 | Status: NOT_YET_RECRUITING